{"id":"https://openalex.org/W2908368114","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.2041","title":"Predicting GBM response to targeted therapeutics using simulation with ex vivo validations.","display_name":"Predicting GBM response to targeted therapeutics using simulation with ex vivo validations.","publication_year":2014,"publication_date":"2014-05-20","ids":{"openalex":"https://openalex.org/W2908368114","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.2041","mag":"2908368114"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.15_suppl.2041","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.2041","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.2041","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017371290","display_name":"Sandeep C. Pingle","orcid":"https://orcid.org/0000-0003-0124-4093","observed_orcids":["https://orcid.org/0000-0003-0124-4093"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandeep C. Pingle","raw_affiliation_strings":["University of California San Diego, La Jolla, CA","Univ. of California, San Diego La Jolla, CA#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Univ. of California, San Diego La Jolla, CA#TAB#","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087107058","display_name":"Zeba Sultana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Zeba Sultana","raw_affiliation_strings":["Cellworks Research India Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026968650","display_name":"Pengfei Jiang","orcid":"https://orcid.org/0000-0003-4127-4502","observed_orcids":["https://orcid.org/0000-0003-4127-4502"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pengfei Jiang","raw_affiliation_strings":["University of California San Diego, La Jolla, CA","Univ. of California, San Diego La Jolla, CA#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Univ. of California, San Diego La Jolla, CA#TAB#","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061675391","display_name":"Rajesh Mukthavaram","orcid":"https://orcid.org/0000-0003-1837-2083","observed_orcids":["https://orcid.org/0000-0003-1837-2083"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajesh Mukthavaram","raw_affiliation_strings":["University of California San Diego, La Jolla, CA","Univ. of California, San Diego La Jolla, CA#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Univ. of California, San Diego La Jolla, CA#TAB#","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070140001","display_name":"Ying S. Chao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ying Chao","raw_affiliation_strings":["University of California San Diego, La Jolla, CA","Univ. of California, San Diego La Jolla, CA#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Univ. of California, San Diego La Jolla, CA#TAB#","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086399567","display_name":"Taher Abbasi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Taher Abbasi","raw_affiliation_strings":["Cellworks Group Inc., San Jose, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Group Inc., San Jose, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102152144","display_name":"Shweta Kapoor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shweta Kapoor","raw_affiliation_strings":["Cellworks Research India Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109350774","display_name":"Ansu Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ansu Kumar","raw_affiliation_strings":["Cellworks Research India Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062184019","display_name":"Shahabuddin Usmani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shahabuddin Usmani","raw_affiliation_strings":["Cellworks Research India Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ashish Agrawal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097570","display_name":"Cellworks Research (India)","ror":"https://ror.org/00wgjgc44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210097570"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ashish Agrawal","raw_affiliation_strings":["Cellworks Research India Ltd., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Ltd., Bangalore, India","institution_ids":["https://openalex.org/I4210097570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108215045","display_name":"Shireen Vali","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shireen Vali","raw_affiliation_strings":["Cellworks Research India Ltd., San Jose, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellworks Research India Ltd., San Jose, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063863193","display_name":"Santosh Kesari","orcid":"https://orcid.org/0000-0003-3772-6000","observed_orcids":["https://orcid.org/0000-0003-3772-6000"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Santosh Kesari","raw_affiliation_strings":["University of California, San Diego, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"15_suppl","first_page":"2041","last_page":"2041"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9218999743461609,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9218999743461609,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.028200000524520874,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.02419999986886978,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":1.0},{"id":"https://openalex.org/keywords/drug-response-prediction","display_name":"drug response prediction","score":0.8019999861717224},{"id":"https://openalex.org/keywords/patient-derived-cell-lines","display_name":"patient-derived cell lines","score":0.7239999771118164},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6129999756813049},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.7620000243186951},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.7570000290870667},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":1.0},{"id":"https://openalex.org/keywords/ex-vivo-validation","display_name":"ex vivo validation","score":0.6029999852180481},{"id":"https://openalex.org/keywords/patient-segmentation","display_name":"patient segmentation","score":0.38999998569488525}],"concepts":[{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.8018255233764648},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7819948196411133},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.6356960535049438},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.6263628005981445},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5243944525718689},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.49898552894592285},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49495190382003784},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.468910813331604},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.46193376183509827},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.43867576122283936},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4333411157131195},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4271904230117798},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.42474842071533203},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.41174018383026123},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3519970774650574},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.35071688890457153},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3320887088775635},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31400802731513977},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28998473286628723},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.24554264545440674},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.14149731397628784},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1224549412727356},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.1192985475063324},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.15_suppl.2041","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.2041","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.2041","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.6499999761581421,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2338031862","https://openalex.org/W2163964590","https://openalex.org/W2598657312","https://openalex.org/W2035731894","https://openalex.org/W2114932870","https://openalex.org/W2582072433","https://openalex.org/W4381799928","https://openalex.org/W2957341147","https://openalex.org/W2079548345","https://openalex.org/W2003857914"],"abstract_inverted_index":{"2041":[0],"Background:":[1],"The":[2,114],"unique":[3],"signature":[4],"of":[5,96,100,124,169,200,212,239,243,272],"a":[6,11,20,121,180,254,282],"patient\u2019s":[7],"tumor":[8,48],"implies":[9],"that":[10],"one-size-fits-all":[12],"treatment":[13],"approach":[14,25,117],"will":[15],"likely":[16],"fail.":[17],"This":[18,138,262],"necessitates":[19],"rationally":[21],"designed":[22],"personalized":[23],"therapeutic":[24,219],"employing":[26],"N=1":[27],"segmentation.":[28],"To":[29],"predict":[30,174,248],"clinical":[31,141,260,296],"responses":[32,161,249,281],"to":[33,51,104,173,216,247,250,256,275,294],"targeted":[34,218,276],"drugs,":[35],"we":[36,92,197,208],"(1)":[37],"employed":[38],"predictive":[39,115],"modeling":[40],"and":[41,59,81,85,107,130,146,158,292],"validated":[42,67,159],"this":[43,195],"retrospectively":[44],"(2)":[45],"used":[46,110],"patient":[47,71,97,156,273],"profiling":[49],"data":[50],"create":[52],"simulation":[53,94,171,245],"avatars":[54,95],"(3)":[55],"screened":[56,151],"drugs":[57,153,251],"prospectively":[58,150],"predicted":[60,198,209],"response":[61,191],"for":[62,237,259,269],"patient-derived":[63,75,101,213],"cell":[64],"lines":[65,103,215],"(4)":[66],"outcomes":[68,142],"ex-vivo":[69],"in":[70,194,266,285],"lines.":[72,98],"Methods:":[73],"Human":[74],"glioblastoma":[76],"(GBM)":[77],"samples":[78],"were":[79,109],"cultured":[80],"characterized":[82],"using":[83,177],"histopathologic":[84],"integrated":[86,135],"genomic":[87],"analyses.":[88],"Using":[89],"these":[90],"data,":[91],"created":[93],"Responses":[99],"GBM":[102,125,214],"erlotinib,":[105],"sorafenib":[106],"dasatinib":[108],"as":[111],"alignment":[112],"datasets.":[113],"simulation-based":[116],"from":[118,179],"Cellworks":[119],"provides":[120],"comprehensive":[122],"representation":[123],"disease":[126],"physiology,":[127],"incorporating":[128],"signaling":[129],"metabolic":[131],"networks":[132],"with":[133],"an":[134,234],"phenotype":[136,145],"view.":[137],"model":[139,172,268,287],"predicts":[140],"based":[143],"on":[144],"biomarker":[147],"assays.":[148],"We":[149,165],"ten":[152],"across":[154],"eight":[155],"profiles":[157],"their":[160],"ex":[162,228],"vivo.":[163],"Results:":[164],"evaluated":[166],"the":[167,170,188,201,210,284],"ability":[168],"drug":[175],"responses,":[176],"results":[178],"recent":[181],"study":[182,263],"by":[183],"Garnett":[184],"et":[185],"al.":[186],"Of":[187],"gene":[189],"mutation-drug":[190],"associations":[192,203],"reported":[193],"study,":[196],"22":[199],"25":[202],"tested":[204],"(>85%":[205],"correlation).":[206],"Importantly,":[207],"sensitivity":[211,271],"various":[217],"agents;":[220],"more":[221],"than":[222],"75%":[223],"predictions":[224],"matched":[225],"our":[226,265],"experimental":[227],"vivo":[229],"results.":[230],"Conclusions:":[231],"There":[232],"is":[233],"unmet":[235],"need":[236],"individualization":[238],"cancer":[240,290],"treatment.":[241],"Use":[242],"innovative":[244],"technology":[246],"may":[252],"provide":[253],"way":[255],"stratify":[257],"patients":[258],"trials.":[261],"validates":[264],"silico":[267,286],"predicting":[270,280],"cells":[274],"therapeutics.":[277],"By":[278],"accurately":[279],"priori,":[283],"enables":[288],"personalizing":[289],"therapy":[291],"promises":[293],"improve":[295],"management.":[297]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2019-01-11T00:00:00"}